Literature DB >> 19848083

Cross-protection between West Nile and Japanese encephalitis viruses in red-winged blackbirds (Agelaius phoeniceus).

Nicole M Nemeth1, Angela M Bosco-Lauth, Richard A Bowen.   

Abstract

Similar to West Nile virus (WNV), Japanese encephalitis virus (JEV) has a history of intercontinental spread, and birds are important for the maintenance and transmission of both of these closely related viruses. We examined viremic and serologic responses of blackbirds (Agelaius phoeniceus), with and without immunity to WNV, following experimental inoculation with two strains of JEV. Japanese encephalitis (JE) viremia was detected in only one of 16 (6.3%) WNV-immune birds, while all 16 nonimmune birds had detectable JE viremia. Two weeks after JEV inoculation, all birds without pre-existing WNV immunity had clearly distinguishable anti-JEV antibodies, while in all birds with pre-existing WNV immunity, antibodies to WNV and JEV were either indistinguishable or the anti-WNV antibody titers were significantly higher. As WNV is endemic throughout much of North America, WNV immunity among birds may dampen transmission while complicating the serologic diagnosis of JEV, should this pathogen be introduced to North America.

Entities:  

Mesh:

Year:  2009        PMID: 19848083     DOI: 10.1637/8574-010109-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  9 in total

Review 1.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity.

Authors:  Angela Bosco-Lauth; Gary Mason; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

3.  North American birds as potential amplifying hosts of Japanese encephalitis virus.

Authors:  Nicole Nemeth; Angela Bosco-Lauth; Paul Oesterle; Dennis Kohler; Richard Bowen
Journal:  Am J Trop Med Hyg       Date:  2012-08-27       Impact factor: 2.345

4.  Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand.

Authors:  Kathryn B Anderson; Robert V Gibbons; Stephen J Thomas; Alan L Rothman; Ananda Nisalak; Ruth L Berkelman; Daniel H Libraty; Timothy P Endy
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

5.  West Nile and St. Louis encephalitis viral genetic determinants of avian host competence.

Authors:  Payal D Maharaj; Angela M Bosco-Lauth; Stanley A Langevin; Michael Anishchenko; Richard A Bowen; William K Reisen; Aaron C Brault
Journal:  PLoS Negl Trop Dis       Date:  2018-02-15

6.  Experimental Usutu Virus Infection in Domestic Canaries Serinus canaria.

Authors:  Emna Benzarti; José Rivas; Michaël Sarlet; Mathieu Franssen; Daniel Desmecht; Jonas Schmidt-Chanasit; Giovanni Savini; Alessio Lorusso; Anne-Sophie Van Laere; Mutien-Marie Garigliany
Journal:  Viruses       Date:  2020-01-31       Impact factor: 5.048

Review 7.  How Central Is the Domestic Pig in the Epidemiological Cycle of Japanese Encephalitis Virus? A Review of Scientific Evidence and Implications for Disease Control.

Authors:  Héléna Ladreyt; Benoit Durand; Philippe Dussart; Véronique Chevalier
Journal:  Viruses       Date:  2019-10-15       Impact factor: 5.048

Review 8.  Experimental infections of wild birds with West Nile virus.

Authors:  Elisa Pérez-Ramírez; Francisco Llorente; Miguel Ángel Jiménez-Clavero
Journal:  Viruses       Date:  2014-02-13       Impact factor: 5.048

Review 9.  Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease.

Authors:  Cécile Beck; Miguel Angel Jimenez-Clavero; Agnès Leblond; Benoît Durand; Norbert Nowotny; Isabelle Leparc-Goffart; Stéphan Zientara; Elsa Jourdain; Sylvie Lecollinet
Journal:  Int J Environ Res Public Health       Date:  2013-11-12       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.